Purpose
To advance physicians' knowledge about von Willebrand Disease (VWD)
Target Audience
This activity has been designed to meet the educational needs of physicians involved in the care of patients with VWD.
Program Overview
Physicians face many challenges in the diagnosis and treatment of VWD. This activity has been designed to address some of these issues, including the newest methods of diagnosis, treatment options such as prophylaxis verses on-demand treatment regimen, and use of factor-replacement therapy for surgery.
Educational Objectives
Upon completion of this activity, participants should be better able to:
- Explain a clinical overview of VWD
- Describe the challenges and newest methods of diagnosis
- Review the latest treatment options applicable to the patient population
Credit Designation
The Postgraduate Institute for Medicine(PIM) designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Accreditation Statement
This activity has been planned and implemented in
accordance with the Essential Areas and Policies of the
Accreditation Council for Continuing Medical Education
(ACCME) through the joint sponsorship of PIM and ProMed Institute.
PIM is accredited by the ACCME to provide continuing medical education for physicians.
Faculty Disclosure Statement
All faculty participating in continuing education activities sponsored by
PIM are expected to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations/materials.
|
|
Original airdates: March 3 and
March 16, 2005
Expiration date: March 2008
Note: This program no longer offers credits
but is still available for review.
Estimated time to complete activity: 1 hour
Login or register to access this activity.
Agenda
5 minutes—Welcome and Introduction
10 minutes—Overview
20 minutes—Diagnosis
10 minutes—Treatment
10 minutes—Questions and Answers
5 minutes—Closing Remarks
|
|
